Regulation of Renal WNK Signaling in Intercalated Cells
闰细胞中肾脏 WNK 信号传导的调节
基本信息
- 批准号:10214600
- 负责人:
- 金额:$ 37.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-07-23 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAldosteroneAnimalsApicalBloodBumetanideCUL3 geneCell Culture TechniquesCell SeparationCellsChloridesComplexCoupledDataDefectDietary PotassiumDiseaseDistalDistal convoluted renal tubule structureEnsureEquilibriumExcretory functionExhibitsGoalsHealthHomeostasisHypokalemiaIn VitroIntercalated CellKidneyKnockout MiceKnowledgeLifeLiquid substanceLysineMaintenanceMeasurementMeasuresMediatingMedicalModelingMolecularMovementNa(+)-K(+)-Exchanging ATPaseNephronsPathway interactionsPhosphorylationPhosphotransferasesPhysiologicalPlasmaPlayPotassiumProcessProtein IsoformsProteinsPumpRegulationRoleSignal PathwaySignal TransductionStressSurfaceSystemTestingUrineWorkbasebasolateral membranecostextracellularfallshyperkalemialarge-conductance calcium-activated potassium channelsnovelresponsesensorshear stresssodium-potassium-chloride cotransporter 1 proteinubiquitin ligaseurinaryvoltage
项目摘要
The kidneys play a primary role in the maintenance of potassium homeostasis. The aldosterone sensitive distal
nephron (ASDN) regulates potassium balance by matching the rate of urinary K+ excretion with changes in
extracellular [K+]. Intercalated cells (ICs) play an important role in this process. Within these cells, apical large
conductance BK channels open in response to shear stress to facilitate flow-induced K+ secretion (FIKS), a
process activated by hyperkalemia. Though ICs mediate the transcellular movement of K+ from the peritubular
interstitium into the tubule lumen, they are unique in that their basolateral K+ entry step is not carried out by
the Na+/K+-ATPase. Instead, current evidence suggests that this process requires a bumetanide-sensitive
Na+-K+-2Cl- cotransporter, NKCC1 (SLC12A2). NKCC1 is activated via direct phosphorylation, a process
mediated by the WNK-SPAK/OSR1 pathway. Consistent with a role for this pathway in FIKS, we find that the
kinase active forms of WNK1 and SPAK are stimulated in ICs during hyperkalemia, likely to activate
basolateral NKCC1 and apical BK channels. This, however, contradicts the current paradigm, which contends
that WNK kinases should be switched off when potassium levels are high in the blood. The overall goal of this
application is to determine the importance of NKCC1 and the WNK-SPAK/OSR1 pathway in FIKS, and to test
a novel mechanism that explains how these proteins are specifically activated in ICs of the ASDN during
hyperkalemia. To accomplish this objective, we will use a variety experimental approaches, including whole
animal studies, transport measurements in isolated perfused tubules, fluorescent cell sorting and isolation of
ICs derived from whole kidney, and in vitro studies in cell culture models. The information gained from these
studies will advance our knowledge of the molecular mechanisms underlying the ASDN’s response to
potassium stress.
孩子们在维持钾稳态中发挥了主要作用。醛固酮敏感的不同
肾单位(ASDN)通过与尿k+排泄率与变化的变化来调节钾的平衡
细胞外[K+]。插入的细胞(IC)在此过程中起着重要作用。在这些单元中,顶部大
电导BK通道响应剪切应力开放,以促进流动诱导的K+分泌(FIKS),A
高钾血症激活的过程。尽管IC介导了k+的跨细胞运动
在管腔腔中的间质,它们的独特之处在于它们的基底外侧K+进入步骤未通过
Na+/K+-ATPase。相反,当前的证据表明,此过程需要对bumetanide敏感
Na+-K+-2Cl- cotransporter,NKCC1(SLC12A2)。 NKCC1通过直接磷酸化激活,这是一个过程
由WNK-SPAK/OSR1途径介导。与Fiks中这一途径的角色一致,我们发现
在高钾血症期间,在IC中刺激了WNK1和SPAK的激酶活性形式,可能会激活
基底外侧NKCC1和顶端BK通道。但是,这与当前的范式相矛盾,该范式认为
当血液中钾水平较高时,应关闭WNK激酶。总体目标
应用是确定NKCC1和WNK-Spak/OSR1途径在FIKS中的重要性,并测试
一种新的机制,解释了如何在ASDN的IC中专门激活这些蛋白质
高钾血症。为了实现这一目标,我们将使用一种多种实验方法,包括整个
动物研究,孤立灌注小管中的转运测量,荧光细胞分类和分离
IC源自整个肾脏和细胞培养模型中的体外研究。从这些中获得的信息
研究将促进我们对ASDN对反应的分子机制的了解
钾胁迫。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
AROHAN R SUBRAMANYA其他文献
AROHAN R SUBRAMANYA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('AROHAN R SUBRAMANYA', 18)}}的其他基金
Regulation of Renal WNK Signaling in Intercalated Cells
闰细胞中肾脏 WNK 信号传导的调节
- 批准号:
10440321 - 财政年份:2019
- 资助金额:
$ 37.54万 - 项目类别:
Regulation of Renal WNK Signaling in Intercalated Cells
闰细胞中肾脏 WNK 信号传导的调节
- 批准号:
9982321 - 财政年份:2019
- 资助金额:
$ 37.54万 - 项目类别:
Regulation of Renal WNK Signaling in Intercalated Cells
闰细胞中肾脏 WNK 信号传导的调节
- 批准号:
10662286 - 财政年份:2019
- 资助金额:
$ 37.54万 - 项目类别:
Epithelial Transport Group Sessions at Experimental Biology 2016
2016 年实验生物学上皮运输小组会议
- 批准号:
9126078 - 财政年份:2016
- 资助金额:
$ 37.54万 - 项目类别:
Characterization and Control of the Renal WNK1 Signaling Pathway
肾脏 WNK1 信号通路的表征和控制
- 批准号:
9040930 - 财政年份:2014
- 资助金额:
$ 37.54万 - 项目类别:
Characterization and Control of the Renal WNK1 Signaling Pathway
肾脏 WNK1 信号通路的表征和控制
- 批准号:
9249040 - 财政年份:2014
- 资助金额:
$ 37.54万 - 项目类别:
Characterization and Control of the Renal WNK1 Signaling Pathway
肾脏 WNK1 信号通路的表征和控制
- 批准号:
8694696 - 财政年份:2014
- 资助金额:
$ 37.54万 - 项目类别:
WNK1 regulation of renal NaCl cotransport
WNK1 对肾脏 NaCl 共转运的调节
- 批准号:
7125600 - 财政年份:2005
- 资助金额:
$ 37.54万 - 项目类别:
相似国自然基金
醛固酮诱导巨噬细胞原位增殖参与肾脏纤维化的机制及益气解毒化瘀中药的拮抗作用
- 批准号:82305121
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
醛固酮瘤丙酸代谢异常通过MMA-肥大细胞-5-羟色胺-PCCA环路促进醛固酮合成的机制研究
- 批准号:82300887
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卤代苯醌对肾素-血管紧张素-醛固酮系统的内分泌干扰作用及肾毒性机制
- 批准号:22206151
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
GNA11/GNAQ和CTNNB1双重突变导致醛固酮瘤和继发性高血压的发病机制探索
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于血钙激活CaSR调控醛固酮合成探讨原发性醛固酮增多症的发病机制
- 批准号:82200880
- 批准年份:2022
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
Central Nervous System Reprogramming of the Control of Blood Pressure Induced by Early Life Stress
早期生活压力引起的血压控制的中枢神经系统重新编程
- 批准号:
10555126 - 财政年份:2023
- 资助金额:
$ 37.54万 - 项目类别:
Targeting a ectonucleotidase in the heart with a monoclonal antibody to prevent post-infarct heart failure
用单克隆抗体靶向心脏中的核酸外切酶以预防梗死后心力衰竭
- 批准号:
10711469 - 财政年份:2023
- 资助金额:
$ 37.54万 - 项目类别:
Stable Isotope Approaches to the Understanding of Potassium Homeostasis
稳定同位素方法了解钾稳态
- 批准号:
10431555 - 财政年份:2022
- 资助金额:
$ 37.54万 - 项目类别:
Role of CTRP1 in Renal Sodium Handling in Obesity-Related Hypertension
CTRP1 在肥胖相关高血压肾钠处理中的作用
- 批准号:
10657843 - 财政年份:2022
- 资助金额:
$ 37.54万 - 项目类别:
CNS sites involved in the cardiovascular and renal effects of nociceptin in rats with heart failure
中枢神经系统部位参与痛敏素对心力衰竭大鼠心血管和肾脏的影响
- 批准号:
10411739 - 财政年份:2022
- 资助金额:
$ 37.54万 - 项目类别: